Citation: sideris k et al.Functional and degenerative mitral regurgitation: one ring fits all thorac cardiovasc surg.2019 sep 23.Doi: 10.1055/s-0039-1696989.Presented at the 46th annual meeting of the german society for thoracic and cardiovascular surgery (dgthg), leipzig, february 11¿14, 2017.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding the mid-term outcomes in patients who underwent mitral valve repair for degenerative mitral regurgitation and functional mitral regurgitation using a rigid three-dimensional ring.All data were collected from a single center between june 2009 and february 2016.The study population included 369 patients and was predominantly male with a mean age of 65 years.All were implanted with medtronic profile 3d annuloplasty rings.No serial numbers were provided.Among all patients, 9 deaths occurred during the initial hospitalization due to cardiac-related causes (5) and non-cardiac-related causes(4).An additional 25 patients died at a mean time of 2.3 years post-implant due to cardiac-related causes (1), non-cardiac-related causes (5), and unknown causes (19).No other details were reported.Based on the available information, medtronic product was not directly associated with the deaths.Among all patients, adverse events included: reoperation/mitral valve re-repair due to ring dehiscence, endocarditis, or systolic anterior motion.Other adverse events observed: mild-moderate-severe mitral regurgitation.Based on the available information, medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|